Skip to main content
SpringerLink
Log in

Anti-inflammatories

Various toxicities, no response to treatment and off-label use: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Tepetam FM, et al. Modified successful desensitization protocol of infliximab in a patient with sarcoidosis unable to tolerate corticosteroids and refractory to alternative therapeutics. Tuberkuloz ve Toraks 70: 397-402, No. 4, Dec 2022. Available from: URL: http://doi.org/10.5578/tt.20229612

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anti-inflammatories. Reactions Weekly 1939, 41 (2023). https://doi.org/10.1007/s40278-023-31449-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-31449-y

Search

Navigation